While many articles such as this discuss the flaws in big pharma’s attempts at a treatment, a small biotech, CytoDyn, has an investigational drug, leronlimab, that is showing fantastic efficacy. This drug is now in FDA Phase 2 trails for mild to moderate infections and Phase 2b/3 for serious illness. It appears to be batting 1000 against the cytokine storm and is restoring patient’s immune response to fight the infection. Several patients have been discharged within only a few days of treatment.

How can we get this on the front page ?